TCL Archive Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation April 19, 2013
TCL Archive Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study May 30, 2008
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research December 15, 1995